학술논문
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia
Document Type
Journal
Author
Cappellini, MD; Cohen, A; Piga, A; Bejaoui, M; Perrone, S; Agaoglu, L; Aydinok, Y; Kattamis, A; Kilinc, Y; Porter, J; Capra, M; Galanello, R; Fattoum, S; Drelichman, G; Magnano, C; Verissimo, M; Athanassiou-Metaxa, M; Giardina, P; Kourakli-Symeonidis, A; Janka-Schaub, G; Coates, T; Vermylen, C; Olivieri, N; Thuret, I; Opitz, H; Ressayre-Djaffer, C; Marks, P; Alberti, D
Source
Subject
Language
English
ISSN
15280020